Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02649894 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT02649894 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 119 participants.
The verdict
NCT02649894, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a new catheter is safe and effective in treating malignant pleural effusions compared to approve catheter.
Interventions
- DEVICE Active Comparator: Approved Uncoated PleurX Indwelling Pleural Catheter
- DEVICE Experimental: Silver Nitrate Coated Indwelling Pleural Catheter (SNCIPC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-04-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02649894
The ClinicalTrials.gov registry entry for NCT02649894 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Comparator: Approved Uncoated PleurX Indwelling Pleural Catheter is the first listed.
NCT02649894 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02649894 about?
NCT02649894 is a clinical study titled "Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter". The purpose of this study is to determine whether a new catheter is safe and effective in treating malignant pleural effusions compared to approve catheter.
What is the current status of trial NCT02649894?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2016-05. Estimated completion is 2018-04-18.
What interventions are being tested in trial NCT02649894?
The interventions under investigation include: Active Comparator: Approved Uncoated PleurX Indwelling Pleural Catheter (DEVICE), Experimental: Silver Nitrate Coated Indwelling Pleural Catheter (SNCIPC) (DEVICE).
Who is sponsoring clinical trial NCT02649894?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.